David D. Chang

13F Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 11.2M shares
Security Ownership: 4.9%

David D. Chang, M.D., Ph.D. ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

2025-11-12 - David D. Chang, M.D., Ph.D. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11.2M shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 4.9% percent ownership of the company. In their previous filing dated 2025-08-08, Chang David D had reported owning 11.1M shares, indicating an increase of 0.88% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
David D. Chang, M.D., Ph.D.	4.9%	-2%	$13.9M	11.2M	+98,190	+0.88%	$1.24	13G/A	9/30/2025	12 Nov 2025 16:37:30
David D. Chang, M.D., Ph.D.	5%		$12.6M	11.1M	+93,628	+0.85%	$1.13	13G/A	6/30/2025	8 Aug 2025 20:13:00
David D. Chang, M.D., Ph.D.	5%	-2%	$15.1M	11M	+138,097	+1.27%	$1.37	13G/A	3/31/2025	9 May 2025 17:49:01
David D. Chang, M.D., Ph.D.	5.1%		$14.9M	10.9M			$1.37	13G/A	12/31/2024	13 Feb 2025 16:29:26